Making a diagnosis of psoriatic arthritis can be challenging, because as many as 10% of patients with psoriatic arthritis may have a positive test result for rheumatoid factor or anticitrullinated peptide...
The US Food and Drug Administration has approved the drug based on the results from the KEEPsAKE-1 and KEEPsAKE-2 randomized, placebo-controlled studies.